Mitotic chromosomal Bcl-2: I. Stable expression throughout the cell cycle and association with isolated chromosomes

Journal of Histochemistry and Cytochemistry

Volumn 47, Issue 2, 1999, Pages 139-149

  Schandl, Cynthia A ^a   Li, Shuli ^a   Re, Gian G ^a   Fan, Weimin ^a   Willingham, Mark C ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Bcl 2; Chromosomes; Immunocytochemistry; Mitosis; Nucleus; Phosphorylation

Indexed keywords

MONOCLONAL ANTIBODY; PROTEIN BCL 2;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; ARTIFACT; CANCER CELL CULTURE; CELL CYCLE; CELL SYNCHRONIZATION; CELLULAR DISTRIBUTION; CHROMOSOME ANALYSIS; FLOW CYTOMETRY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; INTERPHASE; MITOSIS; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ANIMALIA;

EID: 0032944499     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1177/002215549904700203     Document Type: Article

References (24)

1. Alnemri ES, Robertson NM, Fernandes TF, Croce CM, Litwack G (1992) Overexpressed full-length human bcl-2 extends the survival of baculovirus-infected SF9 insect cells. Proc Natl Acad Sci USA 89:7295-7299
2. Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thompson CB (1993) Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597-608
3. Chang BS, Minn AJ, Muchmore SW, Fesik SW, Thompson CB (1997) Identification of a novel regulatory domain in bcl-XI and bcl-2. EMBO J 16:968-977
4. Chomczynski P, Sacchi N (1987) Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159
5. Fan W, Cooper T, Norris JS (1993) Characterization of selective glucocorticoid-dependent responses in a glucocorticoid resistant smooth muscle tumor cell line. J Cell Physiol 156:88-95
6. Fang G, Chang BS, Kim CN, Perkins C, Thompson CB, Bhalla KN (1998) "Loop" domain is necessary for taxol-induced mobility shift and phosphorylation of bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of cytochrome c and apoptosis. Cancer Res 58:3202-3208
7. Haldar S, Jena N, Croce CM (1994) Antiapoptosis potential of bcl-2 oncogene by dephosphorylation. Biochem Cell Biol 72: 455-462
8. Haldar S, Jena N, Croce CM (1995) Inactivation of Bcl-2 by phosphorylation. Proc Natl Acad Sci USA 92:4507-4511
9. Lu Q-L, Hanby AM, Hajibagheri MAN, Gschmeissner SE, Lu P-J, Taylor-Papadimitriou J, Krajewski S, Reed JC, Wright NA (1994) Bcl-2 protein localizes to the chromosomes of mitotic nuclei and is correlated with the cell cycle is cultured epithelial cell lines. J Cell Sci 107:363-371
10. Melton DA, Krieg PA, Rebagliati MR, Maniatis T, Zinn K, Green MR (1984) Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acid Res 12:7035-7056
11. Miyashita T, Reed JC (1993) Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood 81: 151-157
12. Monaghan P, Robertson D, Amos TAS, Dyer MJS, Mason DY, Greaves MF (1992) Ultrastructural localization of BCL-2 protein. J Histochem Cytochem 40:1819-1825
13. Muchmore SW, Sattler M, Liang H, Meadows RP, Harlan JE, Yoon HS, Nettesheim D, Chang BS, Thompson CB, Wong S-L, Ng S-C, Fesik SW (1996) X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature 381:335-341
14. Nunez G, Lendon L, Hockenbery D, Alexander M, McKearn JP, Korsmeyer SJ (1990) Deregulated bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J Immunol 144:3602-3610
15. Oltvai ZN, Milliman CL, Korsmeyer SJ (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609-619
16. Pezzella F, Tse AGD, Cordell JL, Pulford KAF, Gatter KC, Mason DY (1990) Expression of the bcl-2 oncogene protein is not specific for the 14:18 chromosomal translocation. Am J Pathol 137:225-232
17. Reed JC (1997) Double identity for proteins of the Bcl-2 family. Nature 387:773-776
18. Schandl CA, Li S, Re GG, Fan W, Willingham MC (1999) Mitotic chromosomal bcl-2: II. Localization to interphase nuclei. J Histochem Cytochem 47:151-158
19. Schandl CA, Priest DG, Willingham MC (1996) Phosphorylation of bcl-2 is a cell cycle-regulated event. Cell Pharm 3:367-372
20. Sentman CL, Shutter JR, Hockenbery D, Kanagawa O, Korsmeyer SJ (1991) Bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67:879-888
21. Tsujimoto Y, Croce CM (1986) Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc Natl Acad Sci USA 83:5214-5218
22. Willingham MC, Bhalla K (1994) Transient mitotic phase localization of bcl-2 oncoprotein in human carcinoma cells and its possible role in prevention of apoptosis. J Histochem Cytochem 42: 441-450
23. Yang E, Korsmeyer SJ (1996) Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood 88:386-401
24. Yang E, Zha J, Jockel J, Boise LH, Thompson CB, Korsmeyer SJ (1995) Bad, a heterodimeric partner for Bcl-xL and bcl-2, displaces Bax and promotes cell death. Cell 80:285-291